Elevance Health Inc.

NYSE ELV

Elevance Health Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 5.40%

Elevance Health Inc. EBIT Margin is 5.40% for the Trailing 12 Months (TTM) ending September 30, 2024, a 2.75% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Elevance Health Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 5.26%, a -8.80% change year over year.
Elevance Health Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 5.77%, a -2.58% change year over year.
Elevance Health Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 5.92%, a -7.40% change year over year.
Elevance Health Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 6.39%, a 3.71% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

NYSE: ELV

Elevance Health Inc.

CEO	Ms. Gail Koziara Boudreaux
IPO Date	Oct. 30, 2001
Location	United States
Headquarters	220 Virginia Avenue
Employees	104,900
Sector	Health Care
Industries Telehealth Health Insurance & Plans

Description

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Key trends

Past 5 years